https://clinicaltrials.gov/ct2/show/NCT03325790?type=Intr&cond=Meniere+Disease&lupd_s=06%2F04%2F2019&lupd_d=14
Condition : Meniere’s Disease
Interventions : Drug: 200mg SPI-1005 BID; Drug: 400mg SPI-1005 BID; Other: Placebo
Sponsor : Sound Pharmaceuticals, Incorporated
Completed
SPI-1005 for the Treatment of Patients With Meniere’s Disease
NCT03325790
Mon, 30 Oct 2017 12:00:00 EDT
